Movement Disorders Headlines

Movement Disorders β-2 Adrenergic Agonists Linked to α-synuclein Transcription and Risk of PD

β-2 Adrenergic Agonists Linked to α-synuclein Transcription and Risk of PD

β-2 adrenergic agonists might be able to fight Parkinson's disease.

Movement Disorders Parkinson's: Sleep Disturbances Affect Clinical Motor Subtypes, Disability

Parkinson's: Sleep Disturbances Affect Clinical Motor Subtypes, Disability

Patients with postural instability and gait disturbances had worse sleep scores than those with tremor-dominant Parkinson's.

Movement Disorders Increased Mortality in Parkinson's Disease Linked to Low Antidepressant Adherence

Increased Mortality in Parkinson's Disease Linked to Low Antidepressant Adherence

Given the prevalence of depression in Parkinson's disease and the effectiveness of antidepressants, health care providers should promote adherence in clinical practice.

Movement Disorders Age, Gender, and Cognition Predict Weight Loss in Parkinson's Disease

Age, Gender, and Cognition Predict Weight Loss in Parkinson's Disease

Enrollment of patients with only early Parkinson's disease in this trial prevents generalization of the study's findings across the entire Parkinson's population.

Movement Disorders Parkinson's, REM Sleep Disorder Combination Linked to Cognitive Decline

Parkinson's, REM Sleep Disorder Combination Linked to Cognitive Decline

Patients with both Parkinson's and rapid eye movement sleep behavior disorder were much more likely to experience mild cognitive impairment.

Movement Disorders Levodopa-Induced Euphoria May Drive Addictions, Behavior in Parkinson's

Levodopa-Induced Euphoria May Drive Addictions, Behavior in Parkinson's

Patients taking levodopa therapy may experience neuropsychiatric fluctuations characterized by changes in mood, motivation, and anxiety while in ON and OFF states of drug therapy.

Movement Disorders Remote Neurological Care a Feasible Option for Parkinson's Disease

Remote Neurological Care a Feasible Option for Parkinson's Disease

For patient's with Parkinson's disease, virtual house calls from neurologists may be of interest.

Movement Disorders Patients With Intellectual Disability More Susceptible to Movement Side Effects of Antipsychotics

Patients With Intellectual Disability More Susceptible to Movement Side Effects of Antipsychotics

Incidence of neuroleptic malignant syndrome, akathisia, and parkinsonism was higher in the ID group.

Movement Disorders Austedo Wins Second Indication for Tardive Dyskinesia

Austedo Wins Second Indication for Tardive Dyskinesia

Austedo was previously approved for the treatment of chorea in Huntington's disease.

Movement Disorders Exenatide Presents Exciting Therapeutic Possibilities for Parkinson's Disease

Exenatide Presents Exciting Therapeutic Possibilities for Parkinson's Disease

In a disease where there have been few therapeutic developments since dopamine, exenatide offers a promising new channel of exploration.

Movement Disorders FDA Approves Parkinson's Dyskinesia Treatment

FDA Approves Parkinson's Dyskinesia Treatment

Gocovri is the first treatment for dyskinesia approved for patients with Parkinson's disease who are receiving levodopa therapy.

Movement Disorders Algorithm Accurately Predicts Cognitive Decline in Parkinson's Disease

Algorithm Accurately Predicts Cognitive Decline in Parkinson's Disease

Patients with the highest predictive scores faced a greater risk of developing cognitive impairment and dementia in the first 10 years after disease onset.

Movement Disorders Mislabeled Parkinson's Drug Recalled

Mislabeled Parkinson's Drug Recalled

Cyclobenzaprine HCl may potentially lead to life-threatening serotonin syndrome when the drug is taken in combination with selective serotonin reuptake inhibitors.

Movement Disorders Daily Creatine Fails to Show Benefits in Early Huntington's Disease

Daily Creatine Fails to Show Benefits in Early Huntington's Disease

Despite promising results in earlier studies, researchers found no benefit for creatine in patients with early Huntington's disease.

Movement Disorders Parkinson's, ALS Risk Increased in White-Collar Workers

Parkinson's, ALS Risk Increased in White-Collar Workers

There is a higher risk of death from Parkinson's disease or ALS in white collar workers.

Movement Disorders Vision Changes May Precede Parkinson's Disease

Vision Changes May Precede Parkinson's Disease

People who experience changes in vision may be at risk for Parkinson's disease.

Movement Disorders Parkinson's Patients May Face Greater Risk of Melanoma

Parkinson's Patients May Face Greater Risk of Melanoma

There is a 4 times greater risk of developing melanoma in Parkinson's disease, and vice versa.

Movement Disorders Adjunct Therapy for Parkinson's Now Available

Adjunct Therapy for Parkinson's Now Available

Xadago tablets have been launched as add-on therapy for Parkinson's disease.

Movement Disorders Evaluating the Effects of Treatment Conversion for Huntington's Chorea

Evaluating the Effects of Treatment Conversion for Huntington's Chorea

Overnight treatment conversion from tetrabenazine to deutetrabenazine in patients with HD was found to be safe.

Movement Disorders Several Factors May Predict Cognitive Decline in Parkinson's Disease

Several Factors May Predict Cognitive Decline in Parkinson's Disease

Dopamine deficiency, decreases in cortical thickness and volume in certain areas of the brain was predictive of cognitive decline.

Sign Up for Free e-newsletters